CRISPR-based Gene Editing Market Size, Share & Trends Analysis Report
商品番号 : SMB-88146
| 出版社 | Grand View Research |
| 出版年月 | 2025年8月 |
| ページ数 | 120 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 5,950 |
| 種別 | 英文調査報告書 |
CRISPRベースの遺伝子編集市場 – 製品・サービス（CRISPRキット・試薬）、用途別（バイオメディカル、農業）、最終用途別、地域、セグメント別予測による市場規模、成長と動向分析レポート 2025-2033年
CRISPRベースの遺伝子編集の世界市場規模は、2024年には40億1,000万米ドルと推定され、2033年には135億米ドルに達すると予測されており、2025年から2033年にかけて年平均成長率（CAGR）14.7%で成長します。この成長は、遺伝性疾患の増加、研究と技術の進歩、政府の支援策、バイオテクノロジーへの投資の増加によって推進されています。
CRISPR技術とアプリケーションの進歩は、遺伝子編集の精度、効率、そして汎用性を高めることで、市場の成長を著しく加速させています。CRISPR-Casシステムは発見以来、基本的なDNA切断にとどまらず、高度なゲノムエンジニアリングプラットフォームへと進化を遂げてきました。これは、高忠実度Casバリアント、塩基編集、プライム編集といった革新的な技術、そして脂質ナノ粒子やウイルスベクターといった送達メカニズムの改良によって支えられています。これらの改良により、オフターゲット効果の低減、編集効率の向上、そして治療対象疾患の拡大が実現しました。人工知能（AI）と機械学習との統合により、ガイドRNAの設計と標的部位の選択がさらに最適化され、より迅速かつ正確な開発サイクルが可能になりました。この技術の適応性は、複雑な疾患や形質への対処に不可欠な複数の遺伝子の同時改変を可能にするマルチプレックス編集にも対応しています。
これらの進歩により、CRISPRはヒト治療のみならず、農業、産業バイオテクノロジー、診断、環境管理など、新たな応用分野へと拡大しています。農業分野では、CRISPRは気候変動耐性、害虫耐性、栄養強化を備えた作物の創出に活用されており、食料安全保障上の課題に対する解決策を提供しています。診断分野では、SHERLOCKやFELUDAといったCRISPRベースのツールにより、感染症の迅速かつ低コストな検出が可能になっています。また、合成生物学分野では、持続可能なバイオ燃料や素材の生産のための微生物工学にCRISPRが活用されています。CRISPRの応用範囲の拡大と継続的な技術改良は、製薬会社、アグリバイオテクノロジー企業、研究機関からの強力な投資を促しています。この継続的なイノベーションサイクルは、対象市場を拡大し、複数の業界にわたる変革をもたらす技術プラットフォームとしてのCRISPRの地位を強化しています。
CRISPR-based Gene Editing Market Summary
The global CRISPR-based gene editing market size was estimated at USD 4.01 billion in 2024 and is projected to reach USD 13.50 billion by 2033, growing at a CAGR of 14.7% from 2025 to 2033. This growth is driven by the rising prevalence of genetic disorders, advancements in research and technology, supportive government initiatives, and increasing investment in biotechnology.
Advancements in CRISPR Technology & Applications
Advancements in CRISPR technology and applications are significantly accelerating market growth by enhancing precision, efficiency, and versatility in gene editing. Since its discovery, the CRISPR-Cas system has evolved beyond basic DNA cutting into a sophisticated genome engineering platform. It is supported by innovations such as high-fidelity Cas variants, base editing, prime editing, and improved delivery mechanisms such as lipid nanoparticles and viral vectors. These improvements have reduced off-target effects, increased editing efficiency, and broadened the scope of treatable conditions. Integration with artificial intelligence (AI) and machine learning has further optimized guide RNA design and target site selection, enabling faster, more accurate development cycles. Technology’s adaptability also supports multiplexed editing, allowing simultaneous modification of multiple genes crucial for tackling complex diseases and traits.
These advancements also expand CRISPR into new application areas beyond human therapeutics, including agriculture, industrial biotechnology, diagnostics, and environmental management. In agriculture, CRISPR is being applied to create climate-resilient, pest-resistant, and nutrient-enhanced crops, offering solutions to food security challenges. In diagnostics, CRISPR-based tools such as SHERLOCK and FELUDA enable rapid, low-cost detection of infectious diseases. At the same time, in synthetic biology, CRISPR is used to engineer microorganisms for sustainable biofuel and material production. The widening scope of CRISPR applications, coupled with ongoing technical refinements, is attracting strong investments from pharmaceutical companies, agri-biotech firms, and research institutions. This continual innovation cycle expands the addressable market and strengthens CRISPR’s position as a transformative technology platform across multiple industries.
CRISPR-based Gene Editing Market Report Scope
| Report Attribute | Details |
| Market size value in 2025 | USD 4.52 billion |
| Revenue forecast in 2033 | USD 13.50 billion |
| Growth rate | CAGR of 14.7% from 2025 to 2033 |
| Actual data | 2021 – 2024 |
| Forecast period | 2025 – 2033 |
| Quantitative units | Revenue in USD million/billion and CAGR from 2025 to 2033 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Product & service, application, end use, region |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, India, China, Japan, Australia, South Korea, Thailand, Brazil, Argentina, Saudi Arabia, UAE, South Africa, Kuwait |
| Key companies profiled | Revvity, Inc.; Danaher Corporation; GenScript; Merck KGaA; Thermo Fisher Scientific, Inc.; Tocris Bioscience; OriGene Technologies, Inc.; Bio-Rad Laboratories; Bio-Techne; New England Biolabs, Inc. |
| Customization scope | Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Global CRISPR-based Gene Editing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global CRISPR-based gene editing market based on product & service, application, end use, and region:
- Product & Service Outlook (Revenue, USD Million, 2021 – 2033)
- Products
o CRISPR Kits & Reagents
o CRISPR Libraries
o Others
- Services
- Application Outlook (Revenue, USD Million, 2021 – 2033)
- Biomedical
o Therapeutic Development
o By Indication
o Genetic Disorders
o Oncology
o Ophthalmology
o Others
o By Delivery Method
o Ex Vivo
o In Vivo
o Disease Diagnostics
- Agricultural applications
o Plant Engineering
o Farm Animals Engineering
o Others
- End Use Outlook (Revenue, USD Million, 2021 – 2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
- Regional Outlook (Revenue, USD Million, 2021 – 2033)
- North America
o U.S.
o Canada
o Mexico
- Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
- Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
- Latin America
o Brazil
o Argentina
- MEA
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Application Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of genetic disorders
3.2.1.2. Growing investments in biotechnology and healthcare research
3.2.1.3. Advancements in CRISPR technology and applications
3.2.2. Market restraint analysis
3.2.2.1. Ethical concerns surrounding gene editing
3.2.2.2. High costs associated with CRISPR research and development
3.3. CRISPR-based Gene Editing Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Products
4.4.1. Products market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. CRISPR Kits & Reagents
4.4.2.1. CRISPR kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. CRISPR Libraries
4.4.3.1. CRISPR libraries market estimates and forecasts 2021 to 2033 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Services
4.5.1. Services market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Biomedical
5.4.1. Biomedical market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Therapeutic Development
5.4.2.1. Therapeutic development market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2. By Indication
5.4.2.2.1. Genetic Disorders
5.4.2.2.1.1. Genetic Disorders market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2.2. Oncology
5.4.2.2.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2.3. Ophthalmology
5.4.2.2.3.1. Ophthalmology market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2.4. Others
5.4.2.2.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.3. By Delivery Method
5.4.2.3.1. Ex Vivo
5.4.2.3.1.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million
5.4.2.3.2. In Vivo
5.4.2.3.2.1. In vivo market estimates and forecasts 2021 to 2033 (USD Million
5.4.3. Disease Diagnostics
5.4.3.1. Disease diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Agricultural applications
5.5.1. Agricultural applications market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. Plant Engineering
5.5.2.1. Plant engineering market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. Farm Animals Engineering
5.5.3.1. Farm animals engineering market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. Others
5.5.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. CRISPR-based Gene Editing Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global CRISPR-based Gene Editing Market End Use Movement Analysis
6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Contract Research Organizations
6.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Target disease prevalence
7.4.2.4. Regulatory framework
7.4.2.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Target disease prevalence
7.4.3.4. Regulatory framework
7.4.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Target disease prevalence
7.4.4.4. Regulatory framework
7.4.4.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Target disease prevalence
7.5.2.4. Regulatory framework
7.5.2.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Target disease prevalence
7.5.3.4. Regulatory framework
7.5.3.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Target disease prevalence
7.5.4.4. Regulatory framework
7.5.4.5. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Target disease prevalence
7.5.5.4. Regulatory framework
7.5.5.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Target disease prevalence
7.5.6.4. Regulatory framework
7.5.6.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Target disease prevalence
7.5.7.4. Regulatory framework
7.5.7.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Target disease prevalence
7.5.8.4. Regulatory framework
7.5.8.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Target disease prevalence
7.5.9.4. Regulatory framework
7.5.9.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Target disease prevalence
7.6.2.4. Regulatory framework
7.6.2.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Target disease prevalence
7.6.3.4. Regulatory framework
7.6.3.5. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Target disease prevalence
7.6.4.4. Regulatory framework
7.6.4.5. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Target disease prevalence
7.6.5.4. Regulatory framework
7.6.5.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Target disease prevalence
7.6.6.4. Regulatory framework
7.6.6.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Target disease prevalence
7.6.7.4. Regulatory framework
7.6.7.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Target disease prevalence
7.7.2.4. Regulatory framework
7.7.2.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Target disease prevalence
7.7.3.4. Regulatory framework
7.7.3.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Target disease prevalence
7.8.2.4. Regulatory framework
7.8.2.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Target disease prevalence
7.8.3.4. Regulatory framework
7.8.3.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Target disease prevalence
7.8.4.4. Regulatory framework
7.8.4.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Target disease prevalence
7.8.5.4. Regulatory framework
7.8.5.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Revvity, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product/Service benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Danaher Corporation
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product/Service benchmarking
8.4.2.4. Strategic initiatives
8.4.3. GenScript
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product/Service benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Merck KGaA
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product/Service benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Thermo Fisher Scientific, Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product/Service benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Tocris Bioscience
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product/Service benchmarking
8.4.6.4. Strategic initiatives
8.4.7. OriGene Technologies, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product/Service benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Bio-Rad Laboratories
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product/Service benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Bio-Techne
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product/Service benchmarking
8.4.9.4. Strategic initiatives
8.4.10. New England Biolabs, Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product/Service benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global CRISPR-based gene editing market, by region, 2021 – 2033 (USD Million)
Table 3 Global CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 4 Global CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 5 Global CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 6 North America CRISPR-based gene editing market, by country, 2021 – 2033 (USD Million)
Table 7 North America CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 8 North America CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 9 North America CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 10 U.S. CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 11 U.S. CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 12 U.S. CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 13 Canada CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 14 Canada CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 15 Canada CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 16 Mexico CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 17 Mexico CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 18 Mexico CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 19 Europe CRISPR-based gene editing market, by country, 2021 – 2033 (USD Million)
Table 20 Europe CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 21 Europe CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 22 Europe CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 23 UK CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 24 UK CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 25 UK CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 26 Germany CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 27 Germany CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 28 Germany CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 29 France CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 30 France CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 31 France CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 32 Italy CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 33 Italy CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 34 Italy CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 35 Spain CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 36 Spain CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 37 Spain CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 38 Denmark CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 39 Denmark CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 40 Denmark CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 41 Sweden CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 42 Sweden CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 43 Sweden CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 44 Norway CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 45 Norway CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 46 Norway CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 47 Asia Pacific CRISPR-based gene editing market, by country, 2021 – 2033 (USD Million)
Table 48 Asia Pacific CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 49 Asia Pacific CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 50 Asia Pacific CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 51 Japan CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 52 Japan CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 53 Japan CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 54 China CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 55 China CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 56 China CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 57 India CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 58 India CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 59 India CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 60 Australia CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 61 Australia CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 62 Australia CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 63 South Korea CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 64 South Korea CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 65 South Korea CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 66 Thailand CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 67 Thailand CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 68 Thailand CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 69 Latin America CRISPR-based gene editing market, by country, 2021 – 2033 (USD Million)
Table 70 Latin America CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 71 Latin America CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 72 Latin America CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 73 Brazil CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 74 Brazil CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 75 Brazil CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 76 Argentina CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 77 Argentina CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 78 Argentina CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 79 MEA CRISPR-based gene editing market, by country, 2021 – 2033 (USD Million)
Table 80 MEA CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 81 MEA CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 82 MEA CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 83 South Africa CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 84 South Africa CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 85 South Africa CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 86 Saudi Arabia CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 87 Saudi Arabia CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 88 Saudi Arabia CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 89 UAE CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 90 UAE CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 91 UAE CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
Table 92 Kuwait CRISPR-based gene editing market, by product & service, 2021 – 2033 (USD Million)
Table 93 Kuwait CRISPR-based gene editing market, by application, 2021 – 2033 (USD Million)
Table 94 Kuwait CRISPR-based gene editing market, by End Use, 2021 – 2033 (USD Million)
List of Figures
Fig. 1 CRISPR-based gene editing market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Competitive landscape snapshot
Fig. 15 Market trends & outlook
Fig. 16 Porter’s five force analysis
Fig. 17 PESTEL analysis
Fig. 18 CRISPR-based Gene editing market: Product & service outlook key takeaways
Fig. 19 CRISPR-based Gene editing market: Product & service movement analysis
Fig. 20 Products market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 21 CRISPR kits & reagents market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 22 CRISPR libraries market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 23 Others market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 24 Services market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 25 CRISPR-based gene editing market: Application outlook key takeaways
Fig. 26 CRISPR-based gene editing market: Application movement analysis
Fig. 27 Biomedical market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 28 Therapeutic development market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 29 Genetic disorders market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 30 Oncology market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 31 Ophthalmology market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 32 Others market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 33 Ex vivo market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 34 In vivo market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 35 Disease diagnostics market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 36 Agricultural applications market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 37 Plant engineering market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 38 Farm animals engineering market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 39 Others market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 40 CRISPR-based gene editing market: End Use outlook key takeaways
Fig. 41 CRISPR-based gene editing market: End Use movement analysis
Fig. 42 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 43 Academic & research Institutes market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 44 Contract research organizations market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 45 Regional marketplace outlook, 2023 & 2033 (USD million)
Fig. 46 Regional marketplace: Key takeaways
Fig. 47 North America CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 U.S. CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Canada CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Mexico CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 54 Europe CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 UK CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Germany CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 France CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Spain CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Italy CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Denmark CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Sweden CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Norway CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 71 Asia Pacific CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Japan CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 China CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 India CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Australia CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 South Korea CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Thailand CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Brazil CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Argentina CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 South Africa CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Saudi Arabia CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 UAE CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Kuwait CRISPR-based gene editing market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 96 Market participant categorization
Fig. 97 Company market position analysis, 2024
Fig. 98 Strategic framework
Grand View Researchについて
Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ 1
| シングルユーザ | チーム | エンタープライズ |
| USD 2,950 | USD 3,950 | USD 5,950 |
ライセンスタイプ 2
| シングルユーザ | チーム | エンタープライズ |
| USD 3,950 | USD 4,950 | USD 6,950 |
ライセンスタイプ 3
| シングルユーザ | チーム | エンタープライズ |
| USD 4,950 | USD 5,950 | USD 7,950 |
ライセンスタイプ 4
| シングルユーザ | チーム | エンタープライズ |
| USD 5,950 | USD 6,950 | USD 8,950 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス（インディビジュアルライセンス）
- 1名のみレポートファイル（印刷不可）をご利用いただけます。
- チームライセンス
- 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
- コーポレートライセンス
- 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
- 「関連会社」の範囲についてはお気軽にお問い合わせください。
- シングルユーザライセンス（インディビジュアルライセンス）
- 納品形態
- オンラインダウンロード
- 納期
- ご注文後1～7営業日 ※レポートにより異なります。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
最新出版レポート